- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02307734
A Family-Focused Intervention for Asian American Male Smokers
August 30, 2021 updated by: University of California, San Francisco
This project proposes two aims.
The first aim is to evaluate the efficacy of a family-focused intervention in promoting smoking cessation in Chinese and Vietnamese male smokers using a 2-arm cluster randomized controlled trial with assessments at baseline, 6, and 12 months targeting 360 smoker-family dyads.
Half of the participants will be assigned to the proposed intervention, and the remaining half will be assigned to an attention-control condition where they will receive education on healthy eating and physical activity.
The second aim is to explore mediators to identify key psychosocial and behavioral processes that underlie how the intervention affects the processes of quitting and maintaining abstinence in Chinese and Vietnamese smokers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Smoking prevalence remains high in subgroups of Asian American men, particularly among those with low English proficiency (LEP) and immigrants from cultures where smoking prevalence is high, including Chinese and Vietnamese.
The 2011-12 California Health Interview Survey estimates that nearly half (46%) of all Asian male smokers in California are either Chinese or Vietnamese.
The smoking prevalences among LEP Chinese and Vietnamese men were 32% and 43%, respectively, compared to 16% of the general California male population.
The investigators developed a family-focused intervention utilizing lay health worker (LWH) outreach that integrates formative qualitative research and selected constructs from Social Network Theory, Social Cognitive Theory, and the Transtheoretical Model.
The intervention involves 2 small group education sessions with dyads of smokers and family members, and 2 follow-up individual telephone calls delivered by LHWs over 2 months.
Our single-group pilot trial with 96 dyads of Chinese and Vietnamese male daily smokers and their family members showed a high feasibility of recruiting unmotivated smokers (42% were at "precontemplation"), and a promising 7-day point prevalence abstinence rate of 30% at 3 months with independent corroboration from family members.
The first aim of the study is to evaluate the efficacy of the family-focused intervention in promoting smoking cessation in Chinese and Vietnamese male smokers.
The second aim is to explore mediators to identify key psychosocial and behavioral processes that underlie how the intervention affects the processes of quitting and maintaining abstinence.
The investigators will conduct a 2-arm cluster randomized controlled trial (RCT) with assessments at baseline, 6 and 12 months following intervention initiation.
The RCT involves 60 lay health workers (LHWs); each recruits and delivers interventions to 6 dyads of one male daily smoker and one family member from his household, for a total 360 smoker-family dyads.
Half of the LHWs, stratified by Asian subgroup and smoking history, will be randomized to the family-focused intervention group and the other half will be assigned to an attention control condition receiving education on healthy eating.
All participants will receive written information on smoking cessation resources.
The investigators hypothesize that, at 6 and 12 month follow-up, the intervention smokers will be more likely to achieve biochemically verified smoking abstinence (7-day point prevalence), to report having made at least one 24-hour quit attempt, and to report using at least one evidence-based smoking cessation resource (telephone counseling or Quitline, medication, health professional advice) than smokers in the control condition.
Using prospective quantitative data obtained from the RCT, and post-trial dyadic and individual interviews of 12 smokers and 12 family members selected based on abstinence experiences, the investigators will explore mediators at individual, family and social network levels that explain how the intervention affects quitting and maintaining abstinence.
The long-term goal is to understand effective ways to utilize family-based and social outreach strategies to reduce tobacco use disparities in hard-to-reach populations.
Study Type
Interventional
Enrollment (Actual)
680
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94133
- Chinese Community Health Resource Center
-
San Francisco, California, United States, 94109
- Southeast Asian Community Center (SEACC)
-
San Jose, California, United States, 95122
- Vietnamese Voluntary Foundation
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria (for smoker participants):
- Chinese or Vietnamese males
- Age > 18
- Speak Cantonese or Mandarin (major Chinese dialects) or Vietnamese
- Have smoked at least 1 cigarette daily during the past 7 days, have a family member in the household with whom he will participate in the study, plan to stay in the area for the next 3 months (to complete all intervention activities) and can provide a valid phone number and a mailing address (for follow-up assessments and for sending saliva sample collection kits and payments).
Exclusion Criteria (for smoker participants):
- Those who are currently in a smoking cessation program or trying to quit smoking with assistance will be excluded.
Inclusion Criteria (for family participants):
- Family members (male or female) of an eligible smoker
- Age > 18
- Speak Cantonese or Mandarin (major Chinese dialects) or Vietnamese
- Have never smoked or have formerly smoked but have not had any cigarette in the year prior to participation
Exclusion Criteria (for family participants):
- Only one smoker-family dyad from a household may participate.
- They must not live in the same household as their own LHW (or another LHW) or have participated in the study at any time (e.g., focus groups not directly related to the intervention implementation)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Quit Smoking for a Healthy Family
The experimental/intervention study arm focuses on providing smoking cessation education and support through 2 LHW outreach small group educational sessions (4-5 weeks apart) and 2 individual follow-up telephone calls to smoker and family participants separately.
|
The experimental/intervention study arm focuses on providing smoking cessation education and support through 2 LHW outreach small group educational sessions (4-5 weeks apart) and 2 individual follow-up telephone calls to smoker and family participants separately at 2-3 weeks after each group session for a total of 4 intervention contacts over 2 months.
The LHW and dyads will choose the site of sessions, such as the LHW's or a participant's home, or LHW Agency's office.
Each small group session will last 90 minutes, be interactive, and involve sharing personal stories, learning using a flip chart, and setting individual goals.
Each telephone call will be 15- 20 minutes to reinforce progress and provide support.
|
|
Active Comparator: Healthy Living
In this comparison arm, participants will receive the same number of contacts on the same schedule and in the same format (2 small group sessions and 2 telephone calls).
The comparison LHWs will receive training about "Healthy Living" focusing on nutrition and physical activity education.
Participants will also receive the Smoking Cessation Resource Handout.
|
In this comparison arm, participants will receive the same number of contacts on the same schedule and in the same format (2 small group sessions and 2 telephone calls).
The comparison LHWs will receive training about "Healthy Living" focusing on nutrition and physical activity education.
Participants will also receive the Smoking Cessation Resource Handout.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
long-term 7-day point prevalence smoking abstinence (smoker participants)
Time Frame: 12 months
|
Salivary cotinine will be obtained to provide biochemical verification for participants who report abstinence.
A cotinine level of < 12 ng/mL will be considered to verify abstinence.
Since nicotine replacement therapy (NRT) use will also produce positive cotinine assays, for participants reporting concurrent NRT use, we will use independent corroboration from family member in lieu of salivary cotinine verification.
At Month 12, salivary cotinine will be used for biochemical validation of all smokers reporting abstinence.
|
12 months
|
|
number of 24-hour quit attempts (smoker participants)
Time Frame: 12 months
|
self-report of making quit attempts that lasted at least for 24 hours since baseline
|
12 months
|
|
use of smoking cessation resources since program initiation (smoker participants)
Time Frame: 12 months
|
Use of evidence-based smoking cessation resources since program initiation
|
12 months
|
|
at least 50% reduction of the amount of cigarettes smoked per day from baseline
Time Frame: 12 months
|
smoking reduction
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Janice Y Tsoh, PhD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2015
Primary Completion (Actual)
April 30, 2019
Study Completion (Actual)
March 31, 2020
Study Registration Dates
First Submitted
November 24, 2014
First Submitted That Met QC Criteria
December 1, 2014
First Posted (Estimate)
December 4, 2014
Study Record Updates
Last Update Posted (Actual)
September 5, 2021
Last Update Submitted That Met QC Criteria
August 30, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- R01DA036749 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on Quit Smoking for a Healthy Family
-
University of Roma La SapienzaUnknown
-
Basque Health ServiceCompletedSmoking Cessation | COPDSpain
-
Johns Hopkins UniversityCompletedSmoking Cessation | Hypertension
-
University of Santiago de CompostelaMinisterio de Ciencia e Innovación, SpainCompleted
-
University of AarhusActive, not recruitingWeight Loss | Childhood Obesity | Health Behavior | Motivation
-
Rutgers, The State University of New JerseyCompleted
-
Community Volunteers In MedicineAmerican Academy of PediatricsCompletedPediatric Obesity | Overweight and Obesity
-
Oklahoma State University Center for Health SciencesWashington State University; The Chickasaw NationCompletedBody Weight | Blood PressureUnited States
-
Pro-Change Behavior SystemsCompletedSedentary Lifestyle | Stress, Psychological | Healthy Eating
-
MDRCAbt Associates; Public Strategies; Child Trends; Optimal Solutions GroupCompletedChild Behavior | Adolescent Behavior | Family Relations | Low-Income Population | Marital RelationshipsUnited States